Entac Medical LLC
Developing a noninvasive, Class II device that predicts whether a surgical patient will develop postop ileus. The global market is greater than $1 billion.
Entac Medical is developing medical devices for predictive and diagnostic medicine based on a novel platform technology, Previs Audio Spectral Analysis (patents pending). Its first application, PrevisEA, is a late stage, Class II device that is clinically proven to predict post-op ileus (POI) in surgical patients. Predicting POI is a $1 billion global market with no competition. Additional applications and generations of PASAT are being planned.